tiprankstipranks
Advertisement
Advertisement
Roivant Sciences price target raised to $34 from $30 at Jefferies
PremiumThe FlyRoivant Sciences price target raised to $34 from $30 at Jefferies
2M ago
Arbutus Biopharma price target lowered to $5.50 from $7 at Jefferies
Premium
The Fly
Arbutus Biopharma price target lowered to $5.50 from $7 at Jefferies
2M ago
Arbutus Boosted by $2.25 Billion LNP Settlement and Hepatitis B Trial Progress
Premium
Company Announcements
Arbutus Boosted by $2.25 Billion LNP Settlement and Hepatitis B Trial Progress
2M ago
Video: Moderna advances as settlement seen removing share overhang
PremiumThe FlyVideo: Moderna advances as settlement seen removing share overhang
3M ago
Morning Movers: Moderna rises after entering COVID settlement agreement
Premium
The Fly
Morning Movers: Moderna rises after entering COVID settlement agreement
3M ago
Moderna resolves litigation with Arbutus, to pay up to $2.25B in settlement
Premium
The Fly
Moderna resolves litigation with Arbutus, to pay up to $2.25B in settlement
3M ago
Court Narrows Moderna Defenses in Arbutus Patent Dispute
PremiumCompany AnnouncementsCourt Narrows Moderna Defenses in Arbutus Patent Dispute
3M ago
Arbutus Biopharma Secures Mixed Ruling in Moderna Patent Case
Premium
Company Announcements
Arbutus Biopharma Secures Mixed Ruling in Moderna Patent Case
4M ago
Arbutus faces higher bar to argue infringement by Moderna, says Jefferies
Premium
The Fly
Arbutus faces higher bar to argue infringement by Moderna, says Jefferies
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100